Most people who receive a pacemaker live close to what they would have lived without one, especially if they are otherwise healthy. A large population-based study covering over a decade of implants found that men with pacemakers lived about 80% of their expected remaining years, and women about 84%, compared with the general population of the same age and sex.1International Journal of Cardiology. Life expectancy after implantation of a first cardiac permanent pacemaker (1995–2008): A population-based study That gap narrows or widens depending on your underlying heart condition, age, and other health problems, and in some groups disappears altogether.
When Survival Matches the General Population
Not everyone with a pacemaker has the same prognosis, and some groups do remarkably well. Young adults who receive a pacemaker for an electrical conduction problem but have no structural damage to the heart live about as long as age- and sex-matched people who never needed one. In a study following young pacemaker patients for up to 30 years, about 70% survived beyond 20 years, and their overall survival curve tracked the general population closely.2PubMed. Long-term survival after permanent pacemaker implantation in young adults: 30 year experience There was a sharp early dip in the first six months after implantation, but once patients got past that initial period, the curve leveled off. The key dividing line was structural heart disease: young patients who had it fared significantly worse than those who did not.
A similar pattern shows up in patients paced for sick sinus syndrome, a condition where the heart’s natural pacemaker fires too slowly or erratically. Their ten-year survival was nearly identical to what you would expect in a comparable group from the general population.3PubMed. Survival and follow-up after pacemaker implantation: a comparison of patients with sick sinus syndrome, complete heart block, and atrial fibrillation That finding is reassuring for the large share of pacemaker recipients whose underlying problem is primarily electrical rather than structural.
Why the Reason You Need a Pacemaker Matters
The diagnosis that leads to implantation turns out to be one of the strongest predictors of how long you will live afterward. In the same comparative study, patients paced for complete heart block had a ten-year survival rate well below that of a matched general population, and patients paced for atrial fibrillation with slow ventricular rates fared worse still, with only about a quarter alive at ten years.3PubMed. Survival and follow-up after pacemaker implantation: a comparison of patients with sick sinus syndrome, complete heart block, and atrial fibrillation The difference was not simply because one group was older. Even after accounting for what a matched normal population would be expected to survive, the gap persisted.
A more recent three-year study comparing sick sinus syndrome and atrioventricular block patients found that symptom improvement was comparable between the two groups, and short-term mortality did not differ significantly.4PubMed Central. Clinical Outcomes Following PM Implantation: A 3-Year Comparative Study of Sick Sinus Syndrome and Atrioventricular Block But the predictors of death were different in each group. For patients with sick sinus syndrome, the severity of mitral valve leakage mattered most; for those with atrioventricular block, coronary artery disease and the size of the left atrium were more predictive. In practice, this means two people sitting in the same cardiology waiting room with freshly implanted pacemakers can have very different long-term outlooks depending on what brought them there.
Age at Implantation
The majority of pacemaker recipients are older adults, and age itself is an independent predictor of mortality after implantation. Among very elderly patients (age 80 and above), one study found five-year survival of about 45% and eight-year survival around 26%.5PubMed Central. Pacemaker therapy in very elderly patients: survival and prognostic parameters of single center experience Patients aged 90 and older had an even higher risk of death. But it is worth keeping in mind that five-year survival in any group of 85-year-olds, pacemaker or not, is substantially lower than in 65-year-olds. The pacemaker is not what kills them; it is the accumulated burden of age and other conditions.
A study specifically of octogenarians found one-year survival of 90%, dropping to about 32% at five years and 16% at seven years.6SpringerOpen. Predictors of long-term survival prior to permanent pacemaker implantation in octogenarians or older What predicted shorter survival in this age group was not the pacemaker itself but kidney function, low body mass index, a prolonged hospital stay before implantation, and arriving with shortness of breath as the main symptom. All of these point to frailty and multi-organ burden rather than the device.
An older study of elderly pacemaker patients found five-year survival of about 58%, and the authors pointed out that these numbers were surprisingly close to survival rates seen in earlier studies that included all age groups for the first three years.7PubMed. Long-term survival of elderly patients after pacemaker implatation Only in the fourth and fifth years did survival begin to drop faster in the oldest patients. The conclusion was that even in very old people, pacemaker implantation prolongs life and improves quality of life at low surgical risk.
The Conditions That Actually Shorten Survival
A recurring theme across studies is that the pacemaker itself is rarely the problem. What shortens life is the company the pacemaker keeps: the other conditions present at the time of implantation. In a study of patients with pacemakers for sick sinus syndrome, about half of all classifiable deaths were from noncardiac causes, and only about a third were cardiac.8American Heart Journal. Death in patients with permanent pacemakers for sick sinus syndrome Cancer, lung disease, stroke, and infections were driving much of the mortality. The pacemaker was doing its job. The rest of the body was aging on its own schedule.
Kidney disease deserves special mention. Even moderate kidney impairment is a strong predictor of death after pacemaker implantation. One study of older pacemaker patients found that those with an estimated kidney filtration rate below 45 had a meaningfully higher risk of dying, independent of age and other conditions.9PubMed Central. Impact of chronic kidney disease on mortality in older adults treated with pacemaker implantation A separate study looked at the relationship between how much the pacemaker stimulates the right ventricle and progression of kidney disease, finding that heavy right-ventricular pacing can accelerate kidney decline, particularly in patients without diabetes.10Journal of the Formosan Medical Association. Right ventricular pacing burden and progression of renal failure in chronic kidney disease patients with permanent pacemakers This creates a feedback loop in some patients: the pacemaker is necessary for the heart, but the way it paces can stress the kidneys.
Dementia, cancer, low heart-pumping efficiency, and chronic lung disease all show up repeatedly as independent predictors of shorter survival after pacemaker placement. The practical takeaway is that a pacemaker fixes the heart’s electrical timing problem, but it cannot fix everything else going on in the body. When someone asks about pacemaker life expectancy, the answer almost always depends more on these other conditions than on the device itself.
Does the Type of Pacemaker Matter?
The question of whether a dual-chamber pacemaker (which paces both the upper and lower chambers of the heart) does better than a single-chamber device (pacing only the ventricle) has been debated for decades. A large nationwide cohort study found that patients with atrioventricular block who received dual-chamber devices had lower rates of death, heart failure, new atrial fibrillation, and stroke compared with those who got single-chamber pacemakers.11PubMed Central. Dual-chamber vs. single-chamber pacemaker in patients in sinus rhythm with an atrioventricular block: a nationwide cohort study The annual death rate was roughly 9% in the dual-chamber group versus about 11.5% in the single-chamber group.
However, a randomized trial published in the New England Journal of Medicine found no significant difference in annual mortality between single- and dual-chamber pacing, with death rates of about 7% per year in both groups.12PubMed. Single-Chamber versus Dual-Chamber Pacing for High-Grade Atrioventricular Block Observational studies can make dual-chamber pacing look better partly because healthier patients tend to receive dual-chamber devices. The honest summary is that dual-chamber pacing preserves a more natural heartbeat and probably helps certain patients, but it is not a dramatic survival advantage for everyone.
Where You Pace the Heart Is Changing the Equation
A newer development is changing the conversation about pacing and survival. Traditional pacemakers stimulate the right ventricle, which works but can cause the heart to contract in a slightly uncoordinated way over time. This can eventually weaken the heart muscle, especially in people who need pacing most of the time. A technique called left bundle branch area pacing aims the pacing lead at the heart’s natural wiring, preserving a more synchronized contraction.
The results so far are striking. A large study found that patients who received left bundle branch area pacing had roughly half the risk of death compared with those who received traditional right ventricular pacing over four years of follow-up, with an absolute survival difference of nearly 12 percentage points.13European Heart Journal. Left bundle branch area pacing vs right ventricular pacing for atrioventricular block: the MELOS RELOADED study Heart failure hospitalizations and the need for device upgrades were also significantly lower. Another study found that the benefit of this newer pacing approach was concentrated in patients who had the pacemaker working more than 20% of the time.14JACC: Clinical Electrophysiology. Clinical Outcomes in Conduction System Pacing Compared to Right Ventricular Pacing in Bradycardia If you only need pacing occasionally, where the lead sits matters less.
An observational cohort study confirmed the pattern, showing that left bundle branch area pacing was independently associated with about half the risk of death and heart failure hospitalization compared with right ventricular pacing.15PubMed Central. Left Bundle Branch Area Pacing versus Right Ventricular Pacing in Patients with Atrioventricular Block: An Observational Cohort Study This is still a rapidly evolving area, and most of the evidence comes from observational data rather than large randomized trials. But the signal is strong enough that many centers now prefer conduction system pacing when feasible.
Leadless Pacemakers and Complication Trade-Offs
Leadless pacemakers, tiny devices implanted directly inside the heart without the traditional wires running through veins, represent another shift. A systematic review and meta-analysis found that they had far lower rates of lead dislodgement and lung puncture (pneumothorax) compared with traditional pacemakers, and infection rates were negligible.16PubMed Central. Safety and efficacy of leadless pacemakers: A systematic review and meta-analysis The trade-off was a higher rate of cardiac tamponade (a dangerous fluid buildup around the heart from the implant procedure) and more access-site complications where the catheter enters the body.
A meta-analysis found that overall complication rates at one to two years were lower with leadless devices, and infection rates were substantially reduced.17European Heart Journal. Intracardiac leadless pacemaker: long term safety over traditional pacemakers. a systematic review and meta-analysis All-cause mortality, however, did not differ between the two device types. In a five-year follow-up of a Dutch cohort, the rate of major complications excluding device advisories was about 4%, but when advisory-related complications were included, it rose considerably.18Heart Rhythm. Five-year safety and efficacy of leadless pacemakers in a Dutch cohort Leadless pacemakers solve some real problems, especially for patients who are at high risk of infection or who have limited venous access, but they are not a longevity upgrade by themselves.
Device Infections and Why Speed Matters
Infection is one of the most serious complications that can happen after pacemaker implantation. In a study of over one million patients, about 1.1% developed a device infection, and their one-year survival was only about 68%.19PubMed Central. Lead Extraction and Mortality Among Patients With Cardiac Implanted Electronic Device Infection Infections typically appeared several years after the initial implant, not immediately. Extracting the infected leads and hardware was associated with substantially lower mortality, and doing it quickly made it even better: extraction within six days of diagnosis was linked to the greatest survival benefit.
A separate analysis confirmed that lead extraction within 30 days of an infection diagnosis was associated with a roughly 36% lower risk of dying within a year.20The American Journal of Cardiology. Real-World Evidence on Lead Extraction Following Cardiac Implantable Electronic Device (CIED) Infections and Its Association With 1-year Mortality Despite this, the majority of patients in that study did not have extraction within 30 days. Infection after pacemaker placement is uncommon, but when it happens, prompt treatment is critical.
Generator replacement surgery, which most patients will face at least once when the battery wears down (typically every 7 to 15 years depending on the device), also carries some complication risk. A registry study found that about 4% of straightforward pacemaker generator replacements had a major complication, and the rate jumped to nearly 19% when the procedure involved adding new leads or upgrading to a more complex system.21PubMed. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry No one died during the procedures themselves, but this underscores that each device replacement is a moment of real, if small, risk.
Remote Monitoring and Staying Connected to Your Device
Modern pacemakers can transmit data wirelessly to your cardiology team, allowing continuous or near-daily monitoring without an office visit. This is not just a convenience feature. A review of the evidence found that remote monitoring has been associated with improved survival, earlier detection of problems, and longer battery life.22PubMed Central. Remote Patient Monitoring: What Have We Learned and Where Are We Going? The survival benefit was most evident when the monitoring system sent daily alerts and the care team responded quickly.
No randomized trial has proven a survival benefit specifically for pacemaker remote monitoring. But a large observational study of over 269,000 patients, including more than 115,000 with pacemakers, found that remote monitoring was linked to better survival and that higher adherence to the monitoring program correlated with a larger benefit.23Archives of Cardiovascular Diseases. Remote monitoring of pacemakers For patients with pacemakers, keeping up with remote monitoring transmissions is one of the most straightforward things you can do to potentially improve your outcome.
When Pacing Itself Causes Heart Failure
A concern that has received growing attention is pacing-induced heart failure. Because traditional right ventricular pacing forces the heart to beat in a slightly abnormal pattern, some patients develop weakened heart function over time. When this happens, the stakes change significantly. A nationwide cohort study found that patients who developed heart failure after pacemaker implantation had much worse survival, but upgrading their device to cardiac resynchronization therapy (which coordinates both sides of the heart) was linked to a dramatically lower risk of death.24PubMed Central. Long-term mortality and treatment outcomes in pacemaker-associated heart failure: insights from a nationwide propensity-matched study Certain heart failure medications, particularly a class of drugs that blocks both the angiotensin receptor and neprilysin, and beta-blockers, were also independently associated with better survival in this group.
This underscores an evolving understanding: a pacemaker is not a set-it-and-forget-it device. Patients who develop new symptoms like worsening exercise tolerance or fluid retention after pacemaker placement should be evaluated for pacing-induced cardiomyopathy, because upgrading the device or adjusting medications can meaningfully change the trajectory.
Mental Health and Long-Term Outcomes
An aspect of pacemaker survival that gets almost no attention in the popular conversation is mental health. A nationwide cohort study found that pacemaker patients who were diagnosed with any mental health disorder had a ten-year mortality rate of about 54%, compared with 31% among those without such a diagnosis.25PubMed Central. Incidence and Prognostic Implications of Mental Disorders Among Patients With a Permanent Pacemaker: A Nationwide Cohort Study Schizophrenia carried the highest risk, with more than triple the hazard of death. The association was strongest in men and when the mental health diagnosis came within a few years of implantation. This does not mean the mental illness directly kills pacemaker patients; rather, mental health conditions are linked to medication nonadherence, social isolation, and delayed medical care, all of which erode survival.
Deciding to Deactivate a Pacemaker
A question many people do not think about until it becomes pressing is whether a pacemaker can be turned off, and whether doing so is ethically acceptable. Current professional guidelines affirm that deactivating a pacemaker, or any implanted cardiac device, is both ethically and legally permissible when requested by a patient or their surrogate with decision-making capacity.26PubMed. Deactivation of Cardiac Devices at the End of Life: Clinical and Ethical Challenges Guidelines recommend that discussions about device deactivation begin before the device is even implanted, as part of informed consent. In practice, though, these conversations rarely happen.
The practical reality differs between pacemakers and defibrillators. Turning off a defibrillator prevents painful shocks in a dying patient and does not directly hasten death, which makes it relatively straightforward ethically. Turning off a pacemaker is more complex, particularly for patients who are completely dependent on it for every heartbeat. In those cases, deactivation may lead to death within minutes or hours, which some clinicians and families find harder to reconcile even though the ethical principle is the same. A review of device management in terminal illness emphasizes the importance of having these conversations early, ideally as part of advance care planning, so that decisions are not made in crisis.27PubMed Central. Practical and ethical considerations in the management of pacemaker and implantable cardiac defibrillator devices in terminally ill patients For people living with a pacemaker, understanding that deactivation is an option you can discuss proactively removes some of the anxiety around what happens if the device is no longer serving your goals of care.